Bontempi EJ, Cazzulo JJ. Digestion of human immunoglobulin G by the major cysteine proteinase (cruzipain) from Trypanosoma cruzi. FEMS Microbiolog. Letters. 1990; 70: 337-342.
Bua J, Bontempi EJ, Ruiz AM, Segura EL. Antígenos en Tripanosoma cruzi. Rev Arg Microbiol. 1990; 22: 47-66.
Cardoni RL, Rottenberg ME, Segura EL. Increased production of reactive oxygen species by cells from mice acutely infected with T. cruzi. Cell Inmunol. 1990; 128:11-21.
Kaleab B, Ottenhoff T, Converse P, Halapi E, Tadese G, Rottemberg M, Kiessling R. Mycobacterial-induced cytotoxic T cells as well as nonspecific killer cells derived from healthy individuals and leprosy patients. Eur J Inmunol. 1990; 20: 2651-9.
Ouaissi MA, Taibi A, Cornette J, Velge P, Marty R, Loyens M, Esteva M, Rizvi FS, Capron A. Characterization of major surface and excretory-secretory inmunogens of Trypanosoma cruzi trypomastigotes and identification of potential protective antigen. Parasitol. 1990; 100:115-24.
Perez AC, Cura E, Subias E, Lansetti JC, Segura EL. Long-term preservation of blood samples for diagnosis of Trypanosoma cruzi infection. Trop Med. 1990; 41:75-6.
Rottemberg ME, Cardoni RJ, Segura EL. Involvement of L374+, LYT2.2+ T cell subsets and non-T cells in the resistance of mice against Trypanosoma cruzi infection. Inter J Parasitol. 1990; 20(3):397-400.
Rabinovich JE, Wisnivesky-Colli C, Solarz N, GurtlerR. Probability of transmission of Chagas disease by Triatoma infestans (Hemiptera: Reduviidae) in an endemic area of Santiago del Estero, Argentina. Bull World Health Organ. 1990; 68(6): 737-46.
Ruiz AM, Esteva MI, Subias E, Moreno M, de Campanini AR, Velazquez E, Segura EL. Monoclonal antibodies against the flagellar fraction of epimastigote of T. cruzi. II Inmunoprotection against metacyclic trypomastigotes obtained by inmunization of mice with an affinity purified antigen. Mol Biochem Parasitol. 1990; 30:117-26.
Segura EL y Ruiz AM. Enfermedad de Chagas o Tripanosomiasis Americana. En Compendio de Parasitosis humanas producidas por protozoos. Enfermedad de Chagas, Leishmaniasis, Malaria y Toxoplasmosis. Ed. Carlomagno et. al. Instituto Nacional de Chagas Dr. Mario Fatala Chabén. Buenos Aires, Argentina, 1990
Rottenberg ME., Cardoni .L. and Segura EL. Involvement of L3T4+, Lyt 2.2+ T cell subsets and non-T cell in the resistance of mice against Trypanosoma cruzi infection. Int. Parasitol. 1990; 20: 397-400.
Búa J, Bontempi E, Ruiz AM. y Segura, EL. Actualización en antígenos de T. cruzi.Rev. Arg. Microb. 1990; 22, 47-66.
Aulet F, Riarte A, Pattin M, Segura EL, Vazquez M. Chagas disease and kidney transplantation. Transplanting Proceedings. 1991; 23(5): 2653.
Bua JE, Bontempi EJ, Levin M, Orn A, Velazco D, Moreno M, Levi-Yeyati P, Engstrom A, Segura EL, Ruiz AM. Trypanosoma cruzi: cellular and antibody response against the parasite in mice inmunized with a 19-Amino acid synthetic peptide. Exp Parasitol. 1991; 72: 54-62.
Carlomagno MA, Riarte AR, Segura EL. Effects of renuttrition on caloric-deficient mice during T. cruzi infection. Nutr Res. 1991; 11: 1285-91.
Fichera L, Salomón D, Stoka A. Structures properties and inmunological identity of vitelin isolated from triatominae species. Acta Physiol Pharmac Latinoam. 1991; 41(4): 405-15.
Gürtler RE, Cécere MC, Rubel DN, Petersen RM, Schweigmann NJ, Lauricella MA, Bujas MA, Segura EL, Wisnivesky-Colli C. Chagas disease in north-west Argentina infected dogs as a risk factor for the domestic transmission of Trypanosoma cruzi. Trans. Roy. Soc. Trop. Med. Hyg. 1991; 85: 741-745.
Paulone I, Segura EL. The status of transmission of Trypanosoma cruzi in an endemic area of Argentina prior to control attempts. Ann Trop Med Parasitol. 1991; 85(5): 489-97.
Rodriguez JR, Gros E, Stoka AM. Synthesis and biological activity of juvenile hormone (JHA) for T. cruzi. Biorganic and medicinal Chemistry Letters. 1991; V1 (12):679-682.
Rottemberg ME, Cardoni RL, Sinagra A, Riarte A, Rodriguez Nantes I, Lauricella M, Segura El. Trypanosoma cruzi: T-cell-dependent mechanism of resistance during chronic infection. Exper Parasitol. 1991; 73:127-36.
Rottemberg ME, de Titto E, Cardoni R, Segura EL. Respuesta inmune en la infección con T. cruzi. Rev. Arg. Microbiol. 1991; 23: 101-121.
Sanz OP, Cardoni RL, Celentano AM, Rimoldi MT, Sica RE, González Cappa SM. Trypanosoma cruzi: induction of changes in the peripheral nervous system in differents strains of mice. Rev Argent Microbiolog. 1991; 23: 30-4.
Campanini A, Subias E, Esteva M, Ruiz AM y Segura EL. Anticuerpos Monoclonales contra T.cruzi. en Actualizaciones en Inmunología Básica y Aplicada I. Editores: Mazolli A, Barrera C, Giraudo Conesa L, Bonaparte V de y Nejankis M. Buenos Aires, Argentina, 1991; pp 97-98.
Dasso MC, de Titto EH. Electrophoretic analysis of Trypanosoma cruzi proteins. An Asoc Quim Argent. 1992; 80(1-3): 293-304.
Fichera LE, Riarte A. Embryology of Triatoma infestans (Klug) (Hemiptera, Reduviidae), a Chagas disease vector. Rev Inst Med Trop S Paulo. 1992; 34: 211-6.
Forniciari G., Castagna M., Viacava P., Tognetti A., Esteva M., Segura EL. Bevilacqua, G Malattia di Chagas in una mummia peruviana Inca del Museo Nazionale di Antropologia ed Etnologia di Firenze. Archivio per 1 Antropologia e la Etnologia. 1992; 122: 369-376.
Gorelik G., Borda E., Postan M., Gonzalez Cappa SM. T lymphosites from Trypanosoma cruzi infected mice alter heart contractility: participation of arachidonic acid me abolites. J. Mol. Cardiol. 1992; 24: 9-20.
Porcel BM, Bua J, Esteva MI, Bontempi E, Segura EL, Ruiz AM. Obtención de una proteína recombinante inmunogénica en ratones BALB/c semejante al antígeno 1 de 43 KDa. presente en la superficie del Trypanosoma cruzi. An Asoc Quim Argent. 1992; 80 (1-3): 271-83.
Segura EL., Ruiz AM. Trypanosoma cruzi. En Enfermedades Infecciosas y Microbiología Clínica. Ed Perea EJ, Edic. DOYMA, Madrid, España. 1992; Cap. 82: 989-994.
Slimovich R, Rivas C, Velázquez EV, Ruiz AM, Segura EL. Anticuerpos monoclonales anti Leishmania brasiliensis: desarrollo de un ensayo de inmunocompetición y análisis de sueros con reactividad cruzada entre Lehismania Trypanosoma cruzi. An Asoc Quim Argent. 1992; 80 (1-3): 285-92.
Tarleton RL., Koller BH., Latour A., Postan M. Susceptibility of beta-2-microblobulin deficient (MHC class I-negativ, CD8) mice to Trypanosoma cruzi infection. Nature. 1992; 356 (6367): 338-340.
Zwirner NW., Malchioldi EL., Chiaramonte MG., Margni RA., Esteva MI., Fossati CA. Caracterización de un antígeno de Trypanosoma cruzi purificado con anticuerpos monoclonales. Utilidad diagnóstica y análisis de su immunogenicidad. Immunología. 1992; 4:120-127.
Bontempi EJ, Bua J, Aslund L, Porcel B, Henriksson J, Din A, Segura EL, Pettersson U, Ruiz AM. Isolation and characterization of a gene from Trypanosoma cruzi encoding a 46-kilodalton protein with homology to human and rat tyrosine aminotransferase. Mol. Biochem. Parasitol. 1993; (59):253-262.
Chuit R, Paulone I, Wisnivesky-Colli C, Bo R, Pérez AC, Sosa Estani S, Segura EL. Results of a first step toward community-based survillance of transmission of Chagas disease with appropiate technology in rural areas. AM. J. Trop. Med. Hyg. 1993; 46(4): 444-450.
Lauricella MA, Wisnivesky -Colli C, Gurtler R, Pettersen R, Bujas M, Segura EL. Standarization of serological test for detecting anti- Trypanosoma cruzi in dogs. Mem. Inst. Oswaldo Cruz. 1993; 88(3): 413-417.
Ruiz AM, Bua J. y Segura EL, Antígenos del Trypanosoma cruzi: Perspectivas futuras. In Enfermedad de Chagas. Ed Storino R, Milei J, Edic. DOYMA, Madrid, España. 1993; Cap. 32: 629-640.
Segura EL, Esquivel ML, Sosa Estani S, Chuit R. Control de la Enfermedad de Chagas en Argentina. PAMI Científico. 1993; 8:11-26.
Sinagra A, Riarte A, Lauricella MA, Segura EL. Reactivation of experimental chronic Trypanosoma cruzi infection following immunosuppresive treatment by Cyclosporina and betametasona. Transplantation 1993; 55(6):1434-1434.
Sosa Estani S, Velazquez E, Segura EL, Yampotis C, Yelamos M, Albornoz P, Medina L. Quimioterapia en niños en fase indeterminada reciente de enfermedad de Chagas. Medicina (Buenos Aires) 1993; 53 Supl.I: 20-21.
Vázquez MC; Zala C.; Alvarez F, Campanini A, Segura EL, Riarte, A. Evolución de pacientes chagásicos trasplantados renales. Nefrologia XIII. 1993; (2): 57-58.
Cura E, de Titto E, Segura EL. El diagnóstico y su control de calidad en la infección por Trypanosoma cruzi. En: Actualización en Enfermedad de Chagas. Ed. Roberto Madoeri, Christian Madoeri y Mario I. Cámera. Organización Congreso Nacional de Medicina. 1993. PAG?
Rosenstein-Campanini A, Blanco S.B, De Rissio AM., Lansseti J.C., Lauricela M., Segura EL. Transmisión de Trypanosoma cruzi por transfusiones de sangre. En Actualización en Enfermedad de Chagas. Ed.: Roberto Madoeri, Christian Madoeri y Mario Cámera. Organización Congreso Nacional de Medicina. 1993; pp. 237-242.
Bontempi EJ, Porcel BM, Henriksson J, Carlsson L, Rydaker M, Segura EL, Ruiz AM, Pettersson U, Genes for histone H3 in Trypanosoma cruzi. Mol. Biochem. Parasitol. 1994; 66:147-151.
Cardoni RL. Alteraciones de la respuesta inmune en la infección aguda con Trypanosoma cruzi. Revisión. En «Enfermedad de Chagas». Ed. Ed Storino R, Milei J, Edic. DOYMA; Mosby/Doyma. Argentina, Buenos Aires. 1994; cap 7: 87-102.
De Titto E. Bases genéticas de la Enfermedad de Chagas. En «Enfermedad de Chagas». Ed. R Storino R y Milei J. Mosby/Doyma. Argentina, Buenos Aires 1994; cap 6: 75-86.
Esquivel ML. y Segura EL. Estimación del número de infectados chagásicos en Argentina, Medicina (Buenos Aires) 1994; 54:(1) 91-2.
Postan M., Correa R., Ferrans V. and Tarleton RL. In vitro culture of cardiac mast cells from mice experimentally infected with Trypanosoma cruzi. Internat. Arch. Allergy Immunol. 1994; 105: 251-257.
Salomón D. Presencia de Lutzomyia punctigeniculata (Floch et Abonnec) (Diptera:Psychodidae) en la República Argentina. Rev. Soc. Entomológica Argentina. 1994; 53: 1-4.
Segura, E. L.; Esquivel, M. L.; Salomón, D.; Gómez, A.; Sosa Estani, S.; Luna, C. A.; Tulián, L.; Hurvitz, A.; Blanco, S.; Andrés, A.; Zárate, J.; Chuit, R. Participación comunitaria en el Programa Nacional de Control de la Transmisión de la Enfermedad de Chagas. Medicina (Buenos Aires). 1994; 54 (Nº 5/2): 610-611.
Tarleton RL, Sun J, Zhang L, Postan M. Depletion of T-cell subpopulation results in exacerbation of myocarditis and parasitism in experimental Chagas disease. Infect. Immun. 1994; 62:1820-1829.
Segura,E., Esquivel, M., Salomón, O., Sosa Estani, S., Gómez, A., Ibarra, F., Chuit, R. Alternativas de Control de la transmisión de Trypanosoma cruzi, en “Enfermedad de Chagas” Ed. R Storino R y Milei J. Mosby/Doyma. Argentina, Buenos Aires 1994, 641-648.
Viotti R, Virgiliano C, Armenti H, Segura EL, Treatment of chronic Chagas disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. Am. J. Heart. 1994; 127 (1): 151-161.
Mangone, C. A.; Sica, R. E. P.; Pereyra, S.; Genovese, O.; Segura, E.; Riarte, A.; Sanz, O. P.; Segura, M. Cognitive impairment in human chronic Chagas’ disease. Arq. Neuropsiquiatr. 1994; 52 (2): 200-203.
Segura EL, Esquivel ML, Salomón OD, Gómez AO, Luna CA y Sosa Están S. Control y Vigilancia de la Transmisión de Chagas con Participación Comunitaria utilizando Tecnología Apropiada: Manual para Supervisores. INDIECH. 1994.
Segura EL, Esquivel ML, Salomón OD, Gómez AO, Luna CA y Sosa Están S Control y Vigilancia de la Transmisión de Chagas con Participación Comunitaria utilizando Tecnología Apropiada: Manual para Líderes. INDIECH. 1994.
Ruiz, A. Búa, J., Segura, E.L. Antígenos del Trypanosoma cruzi: Perspectivas futuras, en “Enfermedad de Chagas”, Storino R. y Milei J. Ed Mosby/Doyma. Argentina, Buenos Aires 1994; pp.629-640.
Fichera L, Esteva MI, Wimmer Z, Rodríguez JB and Gros EG. Effects of juvenile Hormone Anologues (JHA) on the Development of Tripanosoma cruzi. Z. Naturforch 1995; 50: 578-580.
Henriksson J, Porcel B, Rydlker M, Ruiz AM, Cazzulo JJ, Frasch AC and Pettersson U. Trypanosoma cruzi genome project: Chromosome-specific markers reveal conserved linkage groups in spite of extensive chromosomal size variation. Mol. Biochem. Parasitol.1995; 73: 63-74.
Jazin EE, Bontempi E, Sanchez DO, Aslund L, Henriksson J, Frasch ASCC, Pettersson U. Trypanosoma cruzi exoantigen is a member of a 160 kDa gene family. Parasitology. 1995; 110: 61-69.
Montemartini M, Bua J, Bontempi EJ, Zelada C, Ruiz AM, Santome JA, Cazzulo JJ and Nowickii C. A recombinant Tyrosine aminotransferase from Trypanosoma cruzi has both, Tyrosine Aminotransferase and Alanine Aminotransferase activities. FEMS Microbiol letters. 1995; 133:17-20.
Paveto C, Pereira C, Espinoza J, Montagna A, Farver M, Esteva. M, Flawiá M. and Torres H. The nitric oxide transduction parthway in Trypanosoma cruzi. The Journal of Biological Chemistry. 1995; 270 (8): 16576-9.
Riarte A, Sinagra A, Lauricella MA, Bolomo N, Moreno M, Cossio P. and Segura EL. Chronic Experimental Infection by Trypanosoma cruzi in Cebus apella monkeys. Memorias Do Instituto Oswaldo Cruz. 1995; 90: 1-4.
Rottemberg M, Riarte AR, Sporrong L, Altech J, Petray P, Ruiz AM, Wigzell H. and Orn A. Outcome of infection with different strains of Trypanosoma cruzi in mice lacking CD4 and/or CD8. Inmunology Letters. 1995; 45: 53-60.
Schavartzapel A, Fichera L, Esteva MI, Rodríguez JB. and Gros EG. Desing, Synthesis and anti T. cruzi evaluation of a new class of cell-grawth inhibitors structuralyl related to fenoxycarb. Helvetica Chimica Acta. 1995; 78: 1207-1214.
Segura, EL, Esquivel, ML, Estimación del número de infectados chagásicos en la Argentina. Medicina (Buenos Aires) 1995; 55(2): 186-188.
Cardoni R, Antunez MI, Orn A, Gronvik KO. T Cell Receptor Vb Repertoire in the Thymus and Spleen of Mice Infected with Tripanosoma cruzi. Cellular Inmunology. 1996; 169: 238-245.
Carlomagno M, Leer G, Esteva MI, Hansen D. and Segura EL. Role of Protein Deficiency on the Course of Trypanosoma cruzi Infection and on the Degree of Protection Conferred by a Flagellar Fraction. J. Nut. Immunol. 1996; 4:37-45.
Carlomagno M, Hansen DS, Villacres-Erickson M, Akerblom L Hellman U, Segura EL and Morein B. Immune suppression by Trypanosoma cruzi antigens identified by monoclonal antibodies prepared with T. cruzi iscoms. In New Dimensions in Parasitology. Acta Parasitológica Técnica. Chapter. 1996; 8: 63-69.
Enría D.; Padula, P.; Segura, E.L.; Pini, N.; Edelstein, A.; Riva Posse, C.; Weissenbacher, M.C. Hantavirus Pulmonary Syndrome in Argentina. Possibility of person to person transmission. Medicina (Buenos Aires). 1996; 56, 709-711.
Gürtler RE., Cecere MC, Castañera MB, Canale D, Lauricella M.A, Chuit R.; CohenJ.E. and Segura EL. Probability of infection with Trypanosoma cruzi of the vector Triatoma infestans fed on infected humans and dogs in northwest Argentina. Am. J.Trop. Med. Hyg. 1996; 55 (1): 24-31.
Genovese O, Ballario C, Storino R, Segura EL and Sica RE. Clinical manifestations of peripheral nervous system involvement in human chronic Chagas disease. Arq Neuropsiquiatr. 1996 Jun; 54(2): 190-6.
Hansen DS, Allievi G, Segura EL, Carlomagno M, Morein B and Villacrés-Eriksson M. The flagellar fraction of Trypanosoma cruzi depleted of an immunosuppresive antigen enhances protection to infection and elicits spontaneous T cell responses. Parasite Immunol. 1996; 18: 607-615.
Laucella S, Salcedo R, Castaños Velez E, Riarte A, De Titto E, Patarroyo M, Orn A & Rottenberg M. Increased expression and secretion of ICAM-1 during experimental infection with Trypanosoma cruzi. Parasite Immunology. 1996; 18: 227-139.
Laucella SA, ME Rottenberg and De Titto EH. Papel de las citoquinas en la resistencia y patología durante la infección con Trypanosoma cruzi. Revista Argentina de Microbiología. 1996; 28: 99-109.
Laucella SA, de Titto EH and Segura EL. Epitopes common to Trypanosoma cruzi and mammalian tissues are recognized by natural antibodies: prognosis value in Chagas´disease. Acta Tropica. 1996; 62: 151-162.
Laucella SA, de Titto EH, Segura EL, Orn A and Rottenberg ME. Soluble cell adhesion molecules in human Chagas´ disease: Association with disease severety and stage of infection. Am. J. Trop. Med. Hyg. 1996; 55: 629-634.
Laucella S, Velazquez E, Dasso M, De Titto E. Trypanosoma cruzi and mammalian heart cross-reactive antigens. Acta Tropica. 1996; 61: 223-238.
Laucella S.A., E.H. de Titto, E. L. Segura, A. Orn, M.E. Rottenberg, Soluble cell adhesion molecules in human Chagas´disease: association with disease severity and stage of infection. Am. J. Trop. Med. Hyg. 1996; 55 (6): 629-634.
Porcel BM, Bontempi EJ, Henriksson J, Rydaker M, Aslund L, Segura EL, Pettersson U, Ruiz AM. Trypanosoma rangeli and Trypanosoma cruzi: Molecular Characterization of Genes Encoding putative Calcium-Binding Proteins, Highly Conserved in Trypanosomatids. Exp.Parasitol. 1996; 84: 387-399
Stoka AM. Activity of Juvenile Hormone Analogues on the growth of trypanosoma cruzi, Steroid Biochem. Mole. Biol. 1996; Vol 59 No 5/6: 495-500.
Tarleton RL, Grusby MJ, Postan M & Glimsher LH. Trypanosoma cruzi infection in MHC deficient mice: further evidence for the role of both class I and class II restricted T cells in immune resistance and disease. International lmmunology. 1996; 8:13-22.
Tarleton RL, Nunez M, Zhang L, Heighs M, Postan M. Cytotoxic T cells as potential vaccine candidates for Trypanosoma cruzi infection. En: New Dimensions in Parasitology. Ed. Ali Ozcel, Ege University Publishing Office, Bornova, Turkey. 1996: 71-78.
Weissenbacher M., Cura E.N, Segura E.L., Hortal M., Baek, L.J., Chu Y.K., Lee H.W. Serological evidence of human Hantavirus Infection in Argentia. Bolivia and Uruguay. Medicina (Buenos Aires), 1996; 56: 17-22.
Antúnez MI, Feinstein R, Cardoni RL and Grönvik K-O. T. cruzi. T cell populations in the Peyer’s patches of BALB/c infected mice. Exp. Parasitology. 1997; 87: 58-64.
Antúnez MI, Cardoni RL. Superantígenos: una particular interacción entre microrganismos y el sistema inmune. Medicina (Buenos Aires) 1997; 57: 608-616.
Calderón G, Addlestein A, Enria D. González de La Valle M, Levi S, Martínez V, Miguel S, Padula P, Pini N, Segura EL, Sosa Estani S, Weissenbacher MC, Yadón Z. Manual de procedimientos para la atención y control de la transmisión de Hantavirus que produce Sindrome Pulmonar, Diciembre de 1997 (3ra Edición).
Cardoni R. La respuesta inflamatoria en la infección aguda con Trypanosoma cruzi. Medicina (Buenos Aires) 1997; 57: 227-234.
Cardoni R, Antunez M, Morales C, Rodriguez Nantes I. Release of reactive oxygen species by Phagocytic cells in response to live parasites in mice infected with Trypanosoma cruzi. Am.J. Trop. Med. Hyg. 1997; 56(2): 329-334.
Esquivel ML, Sosa Estani S, Segura EL, Análisis económico de programas de control: Costos y asignación de recursos, Medicina (Buenos Aires). 1997; 55 (Supl. III): 28-29.
FicheraLE, Gomez A, Sosa Estani S, Segura EL. La estrategia de la participación comunitaria con tecnología apropiada para el control de la transmisión de la enfermedad de Chagas. Acta Toxicol. Arg. 5 (1) 15-62.
Garg N, Postan M, Mensa-Wilmot K, Tarleton RL. Glycosylphosphatidylinositols are required for the development of Trypanosoma cruzi amastigotes. lnfection lmmunity. 1997; 65: 4055-4060.
Imaz MS, Esteva M, Velázquez E, Ruiz AM, Segura EL, Marcipar, A. 1997. Inhibition of trypomastigotes infectivity by a monoclonal antibody directed to a glycoconjugated fraction of epimastigotes of Trypanosoma cruzi. Rev. Latinoam. Microbiol. 1997; 39(1-2): 33-46.
Silber A, Búa J, Porcel B, Segura EL, Ruiz AM. Trypanosoma cruzi: Specific Detection of Parasites by PCR in Infected Human and Vectors Using a Set of Primers (BP1/BP2) Targeted to a Nuclear DNA Sequence. Exp.Parasitol. 1997; 85: 225-232.
Sinagra A, Riarte A, Luna C, Campanini A, Segura EL. Leishmania (VianniaBraziliensis): Biological Behavior of Isolates from Argentina Patients, in golden hamsters. Am.J. Trop. Med. Hyg. 1997; 57(2): 115-118.
Zingales B, Rondinelli E, Degrave W, Da Silveira J, Levin M, Le Paslier D, Modabber F, Dobrokhotov B, Swindle J, Kelly J, Aslund L, Hoheisel JD, Ruiz A., Cazzulo JJ, Pettersson U. and Frasch AC. The Trypanosoma cruzi genome initiative. Parasitology Today. 1997; Vol.13 (1): 16-22.
Carriazo SC, Sembaj A, Aguerri AM, Requena JM, Alonso C, Bua J, Ruiz AM, Segura EL and Barral JM. Polymerase chain reaction procedure to detect Trypanosoma cruzi in blood samples from chronic chagasic patients. Diag. Microbiology and Inf. Disease. 1998; 30 (3): 183-186..
Cura EN and Segura, EL. Quality assurance of the serological diagnosis of Chagas disease. Am. J. of Public Health. 1998; 3 (4): 242-248.
Dictar M, Sinagra A, Verón MT, Luna C, Dengra C, De Rissio A, Bayo R, Ceraso D, Segura E, Koziner B, Riarte A. Recipients and donors of bone marrow transplants affected by Chagas disease: management and preemptive therapy of parasitemia. Bone Marrow Transplantation. 1998; 21: 391-393.
Franke de Cazzulo BM, Bernacchi A, Esteva MI, Ruiz AM, Castro JA and Cazzulo JJ. Trypanocidal effect of SKF525A; Proadifen on different developmental forms of Trypanosoma cruzi. Medicina (Buenos .Aires). 1998; 58(4): 415-8.
Franke de Cazzulo BM; Bernacchi A; Esteva M; Ruiz AM; Castro JA; and Cazzulo JJ. Trypanocidal effect of -diethylaminoethyl-diphenylpropylacetate hydrochloride (SKF 52SA; Proadifen) on different developmental foms of Trypanosoma cruzi. Medicina (Buenos Aires) 1998; 58: 415-418.
Gürtler R. E., Cohen J. E., Lauricella M. A., Chuit R., y Segura E. L. Influence of humans and domestic animals on the household prevalence and density of Triatoma infestans populations in northwest Argentina. Am. J. of Trop. Med. Hyg. 1998; 58: 748-758.
Hansen DS, Villacrés-Eriksson M, Akerbiom L, Hellman U, Segura EL, Carlomagno M and Morein B An inmunoaffinity purified Trypanosoma cruzi antigen suppresses antigen specific and mitogen-mediated cellular proliferation through a TGF-B Mediated Mechanism. Scand. J. Inmunol. 1998; 47: 509-516.
Martin M, Arcavi M, Santillan G, Amendoeira MR, de Souza Neves E, Griemberg G, Guarnera E, Garberi JC and Angel S. Detection of human toxopiasma-specific immunogiobulins A, M and G with a recombinat Toxoplasma gondii roP 2 protein Clinical and Diagnostic Laboratory lmmunology. 1998; Sep: 627-631.
Sosa Estani S, Segura EL, Ruiz AM, Velázquez E, Porcel BM, Yampotis C. Efficacy of chemotherapy with Benznidazole in children in indeterminate phase of Chagas disease. Am. J. Trop. Med. Hyg. 1998; 59(6): 526-529.
Sosa Estani S, Campanini A, Sinagra A, Luna C, Peralta M, Coutada V, Medina L, Riarte A, Salomón D, Gómez A y Segura EL. Características Clínicas y Diagnóstico de la Leishmaniasis Mucocutánea en Pacientes de un Area Endémica de Salta, Medicina (Buenos Aires). 1998; 58: 685-691.
Sterin-Borda L, Gorelic G, Postan M, Gonzalez Cappa SM, Borda E. Alterations in cardiac beta-adrenergic receptors in chagasic mice and their association with circulatin beta-adrenoreceptor autoantibodies. Cardiovascular Research 1998; 41, 116-125.
